These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30203897)

  • 1. Evaluation of ovarian and metabolic effects of GnRH modulators in two rat models of polycystic ovary syndrome.
    Patel R; Shah G
    Mol Reprod Dev; 2018 Oct; 85(10):778-789. PubMed ID: 30203897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats.
    Patel R; Shah G
    Arch Med Res; 2018 Apr; 49(3):154-163. PubMed ID: 30104075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats.
    Patel R; Shah G
    Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of postnatal leuprolide acetate treatment on reproductive characteristics in a rodent model of polycystic ovary syndrome.
    Serrano Mujica LK; Bertolin K; Bridi A; Glanzner WG; Rissi VB; de Camargo FL; Zanella R; Prestes OD; Moresco RN; Antoniazzi AQ; Dias Gonçalves PB; Premaor MO; Comim FV
    Mol Cell Endocrinol; 2017 Feb; 442():125-133. PubMed ID: 27988272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
    He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
    Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
    J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of the follicular synchronization and sensitivity of rats with PCOS by AMH during prolonged pituitary downregulation.
    Huang J; Ding Y; Li Z
    Gene; 2019 Dec; 721():144106. PubMed ID: 31499126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.
    Jahan S; Munir F; Razak S; Mehboob A; Ain QU; Ullah H; Afsar T; Shaheen G; Almajwal A
    J Ovarian Res; 2016 Dec; 9(1):86. PubMed ID: 27923406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study.
    Petermann TS; Cartes A; Maliqueo M; Vantman D; Gutiérrez C; Toloza H; Echiburú B; Recabarren SE
    Hum Reprod; 2004 Dec; 19(12):2742-7. PubMed ID: 15358722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
    Rajan RK; M SS; Balaji B
    Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.
    Dey A; Dhadhal S; Maharjan R; Nagar PS; Nampoothiri L
    J Ethnopharmacol; 2022 Jun; 291():115161. PubMed ID: 35271948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
    Huang Y; Zhang X
    Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways.
    Xu J; Dun J; Yang J; Zhang J; Lin Q; Huang M; Ji F; Huang L; You X; Lin Y
    Med Sci Monit; 2020 Jul; 26():e923073. PubMed ID: 32638705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats.
    Haslan MA; Samsulrizal N; Hashim N; Zin NSNM; Shirazi FH; Goh YM
    BMC Complement Med Ther; 2021 Nov; 21(1):291. PubMed ID: 34844580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
    Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
    J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.